1. Scrip

Flu Vaccine Leader Seqirus Invests In Self-Amplifying mRNA

Roberta Duncan To Head Up Progam

 
• By Andrew McConaghie

Seqirus is pursuing self-amplifying RNA, a promising but more technically complex approach which could help it compete in the next generation of flu and pandemic vaccines.

Flu Vaccine NHS
Seqirus has been boosted by better-than-expected flu vaccine sales, but must invest to keep ahead of new competitors

Seqirus is pursuing self-amplifying RNA, a promising but more technically complex approach which could help it compete in the next generation of flu and pandemic vaccines

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip